Table 3. Cox proportional hazard model of cardiac death in HF.
Risk factor | Univariate | Multivariate | ||||
HR | 95% Cl | P-value | HR | 95% Cl | P-value | |
Age | 1.008 | 0.901–1.028 | 0.401 | |||
Male gender | 1.150 | 0.687–1.926 | 0.595 | |||
Systolic blood pressure | 0.977 | 0.954–1.122 | 0.118 | |||
Ischemic etiology | 1.167 | 0.661–2.059 | 0.595 | |||
Atrial fibrillation | 0.892 | 0.526–1.513 | 0.671 | |||
Anemia | 1.487 | 0.879–2.515 | 0.139 | |||
Reduced LVEF (LVEF<50%) | 2.370 | 1.369–4.103 | 0.002 | 2.234 | 1.142–4.371 | 0.019 |
BNP | 2.148 | 1.145–4.028 | 0.017 | 1.465 | 0.764–2.810 | 0.250 |
Aspartate aminotransferase | 2.326 | 1.375–3.937 | 0.002 | 1.856 | 1.021–3.375 | 0.043 |
Alkaline phosphatase | 1.333 | 0.798–2.226 | 0.272 | |||
Gamma-glutamyl transferase | 1.004 | 0.580–1.739 | 0.998 | |||
Sodium | 0.958 | 0.564–1.629 | 0.875 | |||
C-reactive protein | 1.093 | 0.663–1.803 | 0.728 | |||
MELD-XI | 1.973 | 1.178–3.305 | 0.010 | 2.052 | 1.085–3.879 | 0.027 |
BNP, B-type natriuretic peptide; LVEF, left ventricular ejection fraction; MELD-XI, model for end-stage liver disease excluding prothrombin time-international ratio.